Men with low cholesterol face less risk of high-grade prostate cancer
Men with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer — an aggressive form of the disease with a poorer prognosis, according to results of a Johns Hopkins collaborative study.
NSAID Made No Difference to Cancer Growth
To see whether Celebrex (celecoxib) can reduce prostate cancer size and spread, a team from several leading US cancer centers led by Dr. Alan Partin and Dr. Michael Carducci conducted a randomized, double-blind trial enrolling high-risk men before primary treatment with surgery or radiation. They measured the effect of celecoxib on drug-specific biomarkers from prostate tissue obtained at prostatectomy on these men.
For Men, keeping cholesterol low protects against prostate cancer and erectile dysfunction
Statins, drugs widely prescribed to lower cholesterol, may have protective effects on prostate health and on male erectile function. A large Mayo Clinic study co-sponsored by Merck and Kaiser Permanente looked at possible effects of statins on three different aspects of urological health – prostate cancer, erectile dysfunction and prostate enlargement.
Red clover (Trifolium pretense) is a well-known source of isoflavones. Both red clover as such and isoflavones as a class of nutrients have hormonal effects in the prostate. To find about more about the safety of these nutrients when taken as supplements, researchers at the National Institutes of Health looked at the effect on DHEA levels.
Harping on negative consequences of a lack of cancer screening among minorities can actually make African-Americans less likely to go for screening, according to behavioral science research published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.